U.S. flag

An official website of the United States government

NM_001382.4(DPAGT1):c.85A>T (p.Ile29Phe) AND Congenital myasthenic syndrome 13

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jun 24, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003236665.1

Allele description [Variation Report for NM_001382.4(DPAGT1):c.85A>T (p.Ile29Phe)]

NM_001382.4(DPAGT1):c.85A>T (p.Ile29Phe)

Genes:
LOC126861360:BRD4-independent group 4 enhancer GRCh37_chr11:118972216-118973415 [Gene]
DPAGT1:dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q23.3
Genomic location:
Preferred name:
NM_001382.4(DPAGT1):c.85A>T (p.Ile29Phe)
HGVS:
  • NC_000011.10:g.119101571T>A
  • NG_008918.1:g.5505A>T
  • NM_001382.4:c.85A>TMANE SELECT
  • NP_001373.2:p.Ile29Phe
  • NC_000011.9:g.118972281T>A
  • NM_001382.3:c.85A>T
Protein change:
I29F; ILE29PHE
Links:
OMIM: 191350.0010; dbSNP: rs397515328
NCBI 1000 Genomes Browser:
rs397515328
Molecular consequence:
  • NM_001382.4:c.85A>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Congenital myasthenic syndrome 13 (CMS13)
Synonyms:
Myasthenic syndrome, congenital, with tubular aggregates 2; Myasthenic syndrome, congenital, 13, with tubular aggregates
Identifiers:
MONDO: MONDO:0013883; MedGen: C3553645; Orphanet: 353327; Orphanet: 590; OMIM: 614750

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003935143Institute of Medical Genetics and Genomics, Sir Ganga Ram Hospital
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Jun 24, 2023)
inheritedclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedinheritedyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Institute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, SCV003935143.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providedclinical testing PubMed (1)

Description

The heterozygous variant c.85A>T (p.Ile29Phe) has been observed in a proband with motor developmental delay, frequent falls with gait abnormalities, myopathic facies, hypotonia and mild lordotic pressure in a compound heterozygous state with the other variant c.1139C>T (p.Thr380Ile). This variant is observed in 0.0103% gnomAD (aggregated) database (PM2_moderate). DPAGT1 has low rate of benign missense variants with 22 reported pathogenic missense variants (PP2_supporting). It has been previously reported PMID: 25500013 (PP5_supporting)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1inheritedyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 5, 2024